Valvular & structural heart disease

Predictors of long-term structural valve deterioration and failure after transcatheter aortic valve implantation

EuroInterventionPublished Patients with severe aortic valve stenosis enrolled in the Medtronic One Hospital Clinical Service at 10 Italian centres were included in the study

Authors' conclusion

Echo-Doppler-derived ERMPG measured within 90 days from TAVI is an independent predictor of SVD. SVD is associated with high rates of BVF, and it is an independent predictor of all-cause mortality and cardiovascular mortality.

Study context

Population
Patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI) with a CoreValve/Evolut valve, September 2007 to December 2014patients undergoing TAVI with a CoreValve/Evolut valve who met the enrolment criteria
Participants
1,291 patients
Comparison
Early residual mean postprocedural gradient (ERMPG) as predictor of structural valve deterioration (SVD); SVD compared with no SVD for 10-year mortality
  • SVDn = 46
Outcome
SVD
Follow-up
Median 59.4 months

Main finding

As reported in the abstract

Patients with SVD

46

Cumulative incidence rate

3.6%

Further findings

ERMPG as independent predictor of SVD

Adjusted sHR (95% CI)P value
ERMPGMultivariable analysis1.05 (1.01–1.08)P = 0.004
OutcomeEstimateP value
All-cause mortality · 10-yearadjusted hazard ratio 2.12 (95% CI 1.49–3.00)P < 0.001
Cardiac mortality · 10-yearadjusted sHR 5.78 (95% CI 2.63–12.71)P < 0.001

Risk of SVD across tertiles of ERMPG

Significant stepwise increase
P = 0.009

Bioprosthetic valve failure (BVF) among patients with SVD

Of the 46 patients with SVD, had or developed BVF
25 (54.3%)

Original publication

Predictors of long-term structural valve deterioration and failure after transcatheter aortic valve implantation. EuroIntervention. Published 19 January 2026. doi:10.4244/eij-d-25-00575

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.